GLP-1 drugs like Ozempic and Wegovy are now mainstream, with 12% of Americans having tried them, according to a RAND report. Middle-aged women lead adoption, while older men are catching up. Despite effectiveness, side effects like nausea and diarrhea remain common, and 74% of adults don't plan to use these drugs, reflecting caution over safety, cost, and access.